In response to a significant ongoing disruption to the supply of some Isosorbide mononitrate 60mg modified-release preparations, four new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective today 6 September 2024, SSP073, SSP074, SSP075, and SSP076 provides for the following: SSP073 – for every one tablet of Chemydur® 60XL –
Read moreCommunity Pharmacy England Chief Executive Janet Morrison has met with Minister of State for Care Stephen Kinnock, along with two community pharmacy owners/representatives both of whom sit on the Community Pharmacy England Negotiating Team. Minister Kinnock’s brief covers all primary care contracts, including community pharmacy, and he reiterated how central community pharmacies will be to
Read moreNHS England has written to Integrated Care Boards today, providing advice relevant to community pharmacies and general practices ahead of the early release of people from prisons later this month and in October. Read the NHS England letter This follows the Lord Chancellor taking action to avert a prison capacity crisis by introducing a process
Read moreAn animation to tell MPs about the issues and potential of community pharmacy is now available to share. The short video, developed by Community Pharmacy England, has been designed as an introduction to the community pharmacy sector, communicating our key messages to MPs in a concise and engaging way. Released to coincide with MPs’ return
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/08/2024) announced the following final list of price concessions for August 2024: For the full list of price concessions granted for August 2024 please visit our price concession hub
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Naloxone (Nyxoid®) 1.8mg/0.1ml nasal spray unit dose MSN/2024/093 Tier 2 – medium impact Date of issue: 28th August 2024 Naloxone (Nyxoid®) 1.8mg/0.1ml nasal spray unit dose is out of stock until w/c 30th September 2024. Naloxone 1.26mg/0.1ml nasal spray unit dose
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Isosorbide mononitrate 60mg modified-release tablets and capsules. MSN/2024/092 Tier 2 – medium impact Date of issue: 27th August 2024 Chemydur® 60XL tablets are out of stock until mid-September 2024. Monomax® XL 60mg tablets are out of stock until early October 2024.
Read moreClass 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) Drug alert number: EL (24)A/340 Date issued: 27 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) Company name: Chemidex Pharma Ltd
Read moreCommunity Pharmacy England has today released a national report confirming the severe financial pressures putting community pharmacies at risk of closure, threatening patient care and access to services across England. The Pharmacy Pressures Survey 2024: Funding and Profitability Report sets out what pharmacy owners and their teams have told us about the depths of the
Read more
